Caseware UK (AP4) 2025.0.111 2025.0.111 true2025-04-01falseNo description of principal activity87trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 04418965 2025-04-01 2026-03-31 04418965 2024-04-01 2025-03-31 04418965 2026-03-31 04418965 2025-03-31 04418965 c:CompanySecretary1 2025-04-01 2026-03-31 04418965 c:Director1 2025-04-01 2026-03-31 04418965 c:RegisteredOffice 2025-04-01 2026-03-31 04418965 d:PlantMachinery 2025-04-01 2026-03-31 04418965 d:PlantMachinery 2026-03-31 04418965 d:PlantMachinery 2025-03-31 04418965 d:PlantMachinery d:OwnedOrFreeholdAssets 2025-04-01 2026-03-31 04418965 d:CurrentFinancialInstruments d:WithinOneYear 2026-03-31 04418965 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 04418965 d:ShareCapital 2026-03-31 04418965 d:ShareCapital 2025-03-31 04418965 d:RetainedEarningsAccumulatedLosses 2026-03-31 04418965 d:RetainedEarningsAccumulatedLosses 2025-03-31 04418965 d:AcceleratedTaxDepreciationDeferredTax 2026-03-31 04418965 d:AcceleratedTaxDepreciationDeferredTax 2025-03-31 04418965 c:OrdinaryShareClass1 2025-04-01 2026-03-31 04418965 c:OrdinaryShareClass1 2026-03-31 04418965 c:OrdinaryShareClass1 2025-03-31 04418965 c:FRS102 2025-04-01 2026-03-31 04418965 c:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 04418965 c:FullAccounts 2025-04-01 2026-03-31 04418965 c:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 04418965 e:PoundSterling 2025-04-01 2026-03-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 04418965










THE WHITE HOUSE CLINIC LIMITED

Unaudited
Financial statements
Information for filing with the registrar
For the year ended 31 March 2026

 
THE WHITE HOUSE CLINIC LIMITED
 

Company Information


Director
J C Howard 




Company secretary
K L Francis



Registered number
04418965



Registered office
The White House
3 Sandygate Park

Sheffield

South Yorkshire

S10 5TZ





 
THE WHITE HOUSE CLINIC LIMITED
Registered number: 04418965

Balance Sheet
As at 31 March 2026

2026
2025
Note
£
£

Fixed assets
  

Tangible assets
 4 
6,937
8,459

  
6,937
8,459

Current assets
  

Debtors
  
102,487
99,389

Cash at bank and in hand
  
135,528
82,146

  
238,015
181,535

Creditors: amounts falling due within one year
  
(81,684)
(69,625)

Net current assets
  
 
 
156,331
 
 
111,910

Total assets less current liabilities
  
163,268
120,369

Provisions for liabilities
  
(1,057)
(1,288)

Net assets
  
162,211
119,081


Capital and reserves
  

Called up share capital 
 7 
2
2

Profit and loss account
  
162,209
119,079

  
162,211
119,081


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 22 June 2026.



J C Howard
Director

The notes on pages 2 to 5 form part of these financial statements.

Page 1

 
THE WHITE HOUSE CLINIC LIMITED
 

 
Notes to the Financial Statements
For the year ended 31 March 2026

1.


General information

The White House Clinic Limited is a company limited by shares incorporated in England within the United Kingdom. The address of the registered office is given in the company information page of these financial statements.

The financial statements are presented in sterling which is the functional currency of the company.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 2

 
THE WHITE HOUSE CLINIC LIMITED
 

 
Notes to the Financial Statements
For the year ended 31 March 2026

2.Accounting policies (continued)

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Equipment
-
18%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

Page 3

 
THE WHITE HOUSE CLINIC LIMITED
 

 
Notes to the Financial Statements
For the year ended 31 March 2026

2.Accounting policies (continued)

 
2.8

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 9 (2025 - 7).


4.


Tangible fixed assets


Equipment

£



Cost or valuation


At 1 April 2025
67,061



At 31 March 2026

67,061



Depreciation


At 1 April 2025
58,602


Charge for the year on owned assets
1,522



At 31 March 2026

60,124



Net book value



At 31 March 2026
6,937



At 31 March 2025
8,459


5.


Cash and cash equivalents

2026
2025
£
£

Cash at bank and in hand
135,528
82,146

135,528
82,146


Page 4

 
THE WHITE HOUSE CLINIC LIMITED
 

 
Notes to the Financial Statements
For the year ended 31 March 2026

6.


Deferred taxation




2026


£






At 1 April 2025
1,288


Utilised in year
(231)



At 31 March 2026
1,057

The provision for deferred taxation is made up as follows:

2026
2025
£
£


Accelerated capital allowances
1,057
1,288

1,057
1,288


7.


Share capital

2026
2025
£
£
Allotted, called up and fully paid



2 (2025 -2) Ordinary shares of £1.00 each
2
2



8.


Related party transactions

The company operates a directors current account with the sole director which is unsecured, interest free and repayable on demand. The amout owed by the director at the financial year end was nil (2025 : £2,261). 


Page 5